Palomar (NASDAQ:PLMR) Target Raised by Piper Sandler to $90.00

0
19
Business or finance concept : Asia Pacific stock market data and candle stick graph chart on monitor on coins background

Palomar stock has undergone multiple analysts rating changes in the recent past.  Palomar stock Target Raised by   Piper Sandler on 6/29/2020. In a note to investors, the firm issued a new target price of $90.00. The analysts previously had $64.00 target price. Piper Sandler’s price target would indicate a potential upside of 14.50% from the stock’s previous close.

Shares of Palomar traded up $3.86 on Monday, reaching $82.47. 66872 shares of the stock traded hands, compared to its average volume of 523314. Shares of were trading at $82.47 on Monday. The firm’s 50 day moving average is $$68.41 and its 200 day moving average is $53.60.Palomar  has a 12 month low of $78.42 and a 12 month high of $87.14. While on yearly highs and lows, Palomar today has traded high as $82.67 and has touched $78.42 on the downward trend.

Palomar Earnings and What to expect: 

Palomar last announced its earnings data on May 5th, 2020. The reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.11. The company earned $38.02 million during the quarter, compared to analysts’ expectations of $35.72 million. Palomar has generated $1.73 earnings per share over the last year and currently has a price-to-earnings ratio of 51.0. Palomar has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 10th, 2020 based off prior year’s report dates.

Earnings for Palomar are expected to grow by 18.66% in the coming year, from $2.09 to $2.48 per share. The P/E ratio of Palomar is 51.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.99. The P/E ratio of Palomar is 51.04, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 17.90. Palomar has a P/B Ratio of 8.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 7.70%
  • On 6/22/2020 President Heath A Fisher Sell 5,000 at average share price of $82.86 which equates to $414,300.00 in money value.
  • On 6/22/2020 CEO Mac Armstrong Sell 12,500 at average price of  $82.79 with total value of : Not Data Available
  • On 6/22/2020 CFO T Christopher Uchida Sell 600 at average price of  $82.81 with total value of : $49,686.00
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Palomar

  • 5/20/2020 – Palomar was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $68.00 price target on the stock.
  • 5/19/2020 – Palomar was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating.
  • 5/13/2020 – Palomar was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $67.00 price target on the stock.
  • 5/7/2020 – Palomar was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. They now have a $68.00 price target on the stock.
  • See More Analyst Rating at: RATING

Other rating updates by Piper Sandler: 

  • 6/29/2020 – ZoomInfo Technologies is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $59.00 price target on the stock.
  • 6/29/2020 – Legend Biotech is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $50.00 price target on the stock.
  • 6/29/2020 – Leap Therapeutics is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $6.00 price target on the stock.
  • 6/29/2020 – Heritage Commerce had its “overweight” rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock.
  • See More Analyst Rating at: RATING

Palomar (NASDAQ:PLMR) Moving Average Technical Analysis

5 day Moving Average is $$82.61 And 5 day price change is -$4.60 (-5.53%)  with average volume for 5 day average is 441,220. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $81.11 and 20 day price change is $4.18 (5.62%) and average 20 day moving volume is 408,965. 50 day moving average is $68.41  and 50 day price change is $23.36 ( 42.29%)  and with average volume for 50 days is : 427,962. 200 day moving average is $53.60  and 200 day price change is $43.83 (126.06%)  and with average volume for 200 days is : 327,094.

See More Analyst Rating at: RATING